Update on Pediatric Opsoclonus Myoclonus Syndrome

被引:36
作者
Hero, Barbara [1 ]
Schleiermacher, Gudrun [2 ]
机构
[1] Univ Cologne, Childrens Hosp, Dept Pediat Oncol, D-50924 Cologne, Germany
[2] Inst Curie, Paris, France
关键词
opsoclonus myoclonus syndrome; dancing eye syndrome; neuroblastoma; ATAXIA SYNDROME; PARANEOPLASTIC OPSOCLONUS; CHILDRENS CANCER; ANTINEURONAL ANTIBODIES; CEREBELLAR-ATAXIA; NEUROBLASTOMA; RITUXIMAB; AUTOANTIBODIES; FEATURES; THERAPY;
D O I
10.1055/s-0033-1358604
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Opsoclonus myoclonus syndrome (dancing eye syndrome) is a rare paraneoplastic syndrome characterized by opsoclonus, myoclonus, and ataxia, usually accompanied by behavioral abnormalities. In adults, opsoclonus myoclonus syndrome has been reported in association with different types of cancer; whereas in children, the syndrome may be associated with neuroblastic tumors. Although a direct proof is lacking, the syndrome is assumed to be of autoimmune origin. The treatment is corticosteroid based with the addition of other immunosuppressive or immunomodulating drugs if intensification seems necessary. Because of the rarity of the disease, international collaborations as well on research as on therapeutic strategies are urgently needed. A European consortium just started a trial for this rare condition.
引用
收藏
页码:324 / 329
页数:6
相关论文
共 82 条
[1]
Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus [J].
Antunes, NL ;
Khakoo, Y ;
Matthay, KK ;
Seeger, RC ;
Stram, DO ;
Gerstner, E ;
Abrey, LE ;
Dalmau, J .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2000, 22 (04) :315-320
[2]
Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus [J].
Bataller, L ;
Graus, F ;
Saiz, A ;
Vilchez, JJ .
BRAIN, 2001, 124 :437-443
[3]
Autoantigen diversity in the opsoclonus-myoclonus syndrome [J].
Bataller, L ;
Rosenfeld, MR ;
Graus, F ;
Vilchez, JJ ;
Cheung, NKV ;
Dalmau, J .
ANNALS OF NEUROLOGY, 2003, 53 (03) :347-353
[4]
Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus [J].
Bell, Jessica ;
Moran, Cassandra ;
Blatt, Julie .
PEDIATRIC BLOOD & CANCER, 2008, 50 (02) :370-371
[5]
Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome [J].
Blaes, F ;
Fühlhuber, V ;
Korfei, M ;
Tschernatsch, M ;
Behnisch, W ;
Rostasy, K ;
Hero, B ;
Kaps, M ;
Preissner, KT .
ANNALS OF NEUROLOGY, 2005, 58 (02) :313-317
[6]
Treatment with intravenously administered immunoglobulins of the neuroblastoma-associated opsoclonus-myoclonus [J].
BorgnaPignatti, C ;
Balter, R ;
Marradi, P ;
Colamaria, V .
JOURNAL OF PEDIATRICS, 1996, 129 (01) :179-180
[7]
Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome [J].
Brunklaus, Andreas ;
Pohl, Keith ;
Zuberi, Sameer M. ;
de Sousa, Carlos .
ARCHIVES OF DISEASE IN CHILDHOOD, 2012, 97 (05) :461-463
[8]
Outcome and Prognostic Features in Opsoclonus-Myoclonus Syndrome From Infancy to Adult Life [J].
Brunklaus, Andreas ;
Pohl, Keith ;
Zuberi, Sameer M. ;
de Sousa, Carlos .
PEDIATRICS, 2011, 128 (02) :E388-E394
[9]
Rituximab for treatment of opsocionus-myoclonus syndrome in neuroblastoma [J].
Burke, Michael J. ;
Cohn, Susan L. .
PEDIATRIC BLOOD & CANCER, 2008, 50 (03) :679-680
[10]
Improvement of Neurological Status and Quality of Life in Children With Opsoclonus Myoclonus Syndrome at Long-Term Follow-Up [J].
Catsman-Berrevoets, Coriene E. ;
Aarsen, Femke K. ;
van Hemsbergen, Marloes L. C. ;
van Noesel, Max M. ;
Hakvoort-Cammel, Frederique G. A. J. ;
van den Heuvel-Eibrink, Marry M. .
PEDIATRIC BLOOD & CANCER, 2009, 53 (06) :1048-1053